Clinical Trial Update: Pharmacokinetics, Pharmacodynamics, Safety, and Preliminary Efficacy of Subcutaneous Injection of SHR-1905 in Adolescent Asthmatic Subjects - an Open-label, Single-dose Phase II Clinical Study [Phase 2]

View source ↗

Summary

Open-label Phase II study in adolescents with asthma evaluating the pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy of a subcutaneous SHR-1…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• SHR-1905

Snippet

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Conditions: Adolescent Asthma | Phase 2 | Status: COMPLETED